Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study

por Zhou, Yu-Wen, Wang, Jia-Ling, Li, Qing-Fang, He, Yuan-Lin, Li, Lin-Juan, Liu, Rui-Zhi, Chen, Ye, Zhang, Shuang, Qiu, Meng, Liu, Ji-Yan
Publicado 2022